GF Fund Management’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
Other funds holding DSGN
DTC
BBA
GF Fund Management's DSGN Position: Q3 2026 in Review
GF Fund Management increased its Design Therapeutics (DSGN) stake by 8.8% in Q3 2026, buying an estimated $1.46K and bringing the position to 1,315 shares worth $16.5K. The position accounts for ﹤0.01% of the portfolio, ranked #509.
GF Fund Management first reported a position in DSGN in Q4 2024 and has held it in 8 quarters since. The position peaked at $17.5K in Q2 2026. 142 funds tracked by Wall St. Rank hold DSGN as of Q3 2026.
- GF Fund Management held 1,315 shares of Design Therapeutics worth $16.5K as of Q3 2026.
- GF Fund Management bought 106 Design Therapeutics shares in Q3 2026, an estimated $1.46K.
- Design Therapeutics made up ﹤0.01% of GF Fund Management's portfolio in Q3 2026, its #509 holding.
- GF Fund Management first reported a position in Design Therapeutics in Q4 2024 and has held it in 8 quarters since.
- GF Fund Management's Design Therapeutics position peaked at $17.5K in Q2 2026.
- 142 funds tracked by Wall St. Rank held Design Therapeutics as of Q3 2026.
Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.